Aureobasidium melanigenum catheter-related bloodstream infection: a case report

BMC Infect Dis. 2022 Apr 5;22(1):335. doi: 10.1186/s12879-022-07310-9.

Abstract

Background: Aureobasidium melanigenum is a ubiquitous dematiaceous fungus that rarely causes invasive human infections. Here, we present a case of Aureobasidium melanigenum bloodstream infection in a 20-year-old man with long-term catheter use.

Case presentation: A 20-year-old man receiving home care with severe disabilities due to cerebral palsy and short bowel syndrome, resulting in long-term central venous catheter use, was referred to our hospital with a fever. After the detection of yeast-like cells in blood cultures on day 3, antifungal therapy was initiated. Two identification tests performed at a clinical microbiological laboratory showed different identification results: Aureobasidium pullulans from matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, and Cryptococcus albidus from a VITEK2 system. Therefore, we changed the antifungal drug to liposomal amphotericin B. The fungus was identified as A. melanigenum by DNA sequence-based analysis. The patient recovered with antifungal therapy and long-term catheter removal.

Conclusion: It is difficult to correctly identify A. melanigenum by routine microbiological testing. Clinicians must pay attention to the process of identification of yeast-like cells and retain A. melanigenum in cases of refractory fungal infection.

Keywords: Aureobasidium melanigenum; Catheter-related bloodstream infection; DNA sequence-based identification; Dimorphic fungus.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antifungal Agents / therapeutic use
  • Aureobasidium
  • Central Venous Catheters*
  • Humans
  • Male
  • Mycoses* / drug therapy
  • Sepsis* / drug therapy
  • Young Adult

Substances

  • Antifungal Agents